Genedrive (LON:GDR)‘s stock had its “buy” rating reissued by Peel Hunt in a research report issued on Tuesday. They presently have a GBX 152 ($2.10) target price on the stock. Peel Hunt’s price objective indicates a potential upside of 322.22% from the stock’s previous close.
Shares of Genedrive (GDR) opened at GBX 36 ($0.50) on Tuesday. The company has a market cap of $5.75 and a P/E ratio of -102.86. Genedrive has a 12 month low of GBX 25 ($0.35) and a 12 month high of GBX 45.32 ($0.63).
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3259042/peel-hunt-reaffirms-buy-rating-for-genedrive-gdr.html.
Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia.
Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.